A carregar...

Intra‐ and inter‐subject variability for increases in serum ketone bodies in patients with type 2 diabetes treated with the sodium glucose co‐transporter 2 inhibitor canagliflozin

Sodium glucose co‐transporter 2 (SGLT2) inhibitors have been associated with increased serum ketone body levels in patients with type 2 diabetes mellitus (T2DM). In the present analysis we evaluated serum ketone body levels and variability in 1278 Japanese patients with T2DM treated with canaglifloz...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Diabetes Obes Metab
Main Authors: Polidori, David, Iijima, Hiroaki, Goda, Maki, Maruyama, Nobuko, Inagaki, Nobuya, Crawford, Peter A.
Formato: Artigo
Idioma:Inglês
Publicado em: Blackwell Publishing Ltd 2018
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5947648/
https://ncbi.nlm.nih.gov/pubmed/29341404
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.13224
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!